<DOC>
	<DOCNO>NCT02090374</DOCNO>
	<brief_summary>The investigator propose development range nasal spray challenge model study way nose respond different type nasal challenge elicit different form inflammation . The investigator carry nasal challenge bacterial viral component allergen . In way nasal upper respiratory tract mucosa challenge stimulus immune system , cause various type inflammation . Samples take blot nostril surface scrap tiny surface sample . The nose sprayed substance single part bacteria virus , allergen . The material deliver nasal spray high purity sterile , contain live bacteria virus . The nasal spray substance contain molecular pattern recognise foreign immune system , right dose stimulate immune system , cause mild nasal inflammation . The study employ noninvasive method sample use absorptive strip . These strip look feel like tissue paper , applied nostril period 1 min . A pinhead-sized tissue sample take inside nose , use small disposable sterile plastic probe tiny scoop end . In nasal line fluid tissue sample , measurement take range molecule cell protect infection help immune response . By spray nose challenge agent manner , nasal immune response assess , help u good understand human immune system cell molecules respond bacteria virus . In future , may allow test new drug vaccine , see decrease stop inflammation nasal challenge .</brief_summary>
	<brief_title>Development Human Nasal Challenge Models With Microbial Constituents Grass Pollen</brief_title>
	<detailed_description>STUDY DESIGN AND METHODOLOGY The study involve 3 part different nasal spray challenge administer subject : 1 . Bacterial viral component , comprise one follow particular patient ; 1 . MPLA ( monophosphoryl lipid A ) resemble bacterial lipopolysaccharide 2 . PolyIC ( polyinosinic cytidylic acid ) : viral component 3 . PolyICLC ( polyIC stabilise polyLlysine ) : viral component 4 . Resiquimod : viral mimic 2 . Tuberculin : partially purify protein derivative ( PPD ) Mycobacterium bovis , bacteria cause TB . 3 . Allergen : The nasal spray challenge agent Timothy grass pollen . RECRUITMENT The aim recruit total 174 subject . Subjects identify advertisement newspaper , poster campus , GP service , outpatient clinic St. Mary 's hospital include TB clinic St. Mary 's Hospital . We gain fully inform consent . All data manage per GCP local Information Governance guideline . NUMBER OF SUBJECTS AND DOSING PART 1 : Nasal ascend dose challenge microbial constituent use MPLA , polyIC , polyICLC resiquimod . This divided part A part B . PART 1A ( n=32 ) : Incremental Ascending Dose Study base Tolerability SAM . 4 cohort 8 healthy volunteer ( 4 8 allergy grass pollen , house dust mite , history hay fever ) . One cohort microbial constituent . Each cohort give nasal saline control challenge three ascend dos nasal microbial constituent challenge : - 10μg microbial constituent 100μl saline - 100μg microbial constituent 100μl saline - 500μg microbial constituent 100μl saline PART 1B ( n=64 ) : Single Top Dose Additional Special Sampling Probe ( SSP ) Curettage , Single Cohort 16 Healthy Volunteers ( 8 16 allergy grass pollen , housedust mite , history hay fever ) . Each subject give saline control single top dose establish tolerability &amp; SAM response . RESIQUIMOD : Part B see 10μg per nostril give 36 volunteer : 12 allergic asthmatic 12 atopic volunteer 12 non-atopic volunteer PART 2 : Nasal ascend dose challenge tuberculin . This divided part A part B . PART 2A ( n=16 ) : This comprise total 16 latent TB ( LTB ) subject , This group subdivide 4 cohort 4 subject accord dose tuberculin administered; - 0.1 TU 100μl , n = 4 - 1.0 TU 100μl , n = 4 - 2.0 TU 100μl , n = 4 - 5.0 TU 100μl , n = 4 Each cohort 1 challenge . The start dose low 0.1 TU . If well tolerate , subject proceed next high dose 1.0 TU . If also well tolerate , subject proceed next high dose 2.0 TU high dose 5.0 TU group ensure safety subject time . PART 2B ( N=16 ) : Top dose additional sampling . This comprise 16 people two group ( 8 healthy volunteer 8 subject latent TB ) . Group 1 : Latent TB subject , . people = 8 This group receive top dose ( 5-10.0 TU ) tuberculin challenge . Out 8 subject group , 2 receive placebo ( saline dummy spray ) remain 6 give tuberculin spray challenge . Group 2 : Healthy volunteer , . people = 8 This group also receive top dose ( 5-10.0 TU ) tuberculin challenge , subject tolerability . Out 8 subject , 2 receive placebo ( saline dummy spray ) remain 6 give tuberculin spray challenge PART 3 ( n=46 ) : Nasal Allergen Challenge Timothy Grass Pollen Initially 30 people shall study : one group 12 people hay fever , one group 12 people asthma grass pollen allergy , group 6 people nonallergic asthma . In additional group,16 people hay fever shall study take continuous sample surface nasal line fluid use special sample probe ( SSP ) follow nasal spray challenge . 1 . Group 1 : people hay fever , n = 12 2 . Group 2 : people allergic asthma , n = 12 3 . Group 3 : healthy , nonatopic people , n = 6 4 . Additional Group 4 : people hay fever , n=16 NASAL PROCEDURES IN THE STUDY 1 . Nasal wash ( nasal lavage ) : At start day , nasal washing nose carry pass small volume salt water ( saline ) fluid nose . This procedure carry procedure clean nose . The fluid obtain nasal washing discard analyse . 2 . Nasal line fluid absorption ( nasosorption SAM ) : A small strip absorbent material , look feel like soft tissue paper , use absorb moisture inside surface nostril . The special absorptive paper place inside nostril leave period 2 minute absorb nasal line fluid remove , gently suck fluid like blot paper . Putting paper nose tickle , cause eye water little . However , nasosorption hurt method prove well tolerated baby , child adult . The paper absorb nasal fluid many substance produce nasal cell extract paper measure laboratory . 3 . Nasal scrape ( nasal curettage Rhinoprobe ) : A small sterile disposable plastic probe insert nose gently press inside surface line nostril . The 3 inch long probe tiny scoop end , barely see . 24 tiny sample nostril ( pinhead , 2mm , tissue ) take part nose reduce nerve supply limit discomfort . Taking sample cause bleeding , may cause mild discomfort , may make eye water slightly . The probe collect nasal cell surface nostril sent analysis . This method perform many adult , child , baby , well tolerate . 4 . Special Sampling Probe ( SSP ) : The nasal surface line fluid may also collect use special sample probe SSP use electrospray bounce droplet nasal line fluid . This do continuously sample hour single nostril . When use special sample probe ( SSP ) people 's nose , slight tickle sensation sample take . This barely notice . STATISTICAL ANALYSIS The distribution data assess ShapiroWilks test , determine whether data normal ( parametric ) non-normal ( non-parametric ) distribution . Normal data display graphically : - arithmetic mean standard error mean ( SEM ) - mean SDs - mean confidence interval ( CIs ) Non-normal data display graphically : Box-whisker : median , quartile , range For non-normal data difference baseline measure active challenge agent ( different dos ) placebo time point , AUC calculate . The difference AUC placebo ( active placebo ) calculate , significance test nonparametric Wilcoxon sign rank test ( single population ) . Area curve ( AUC ) shall sue different define time depend nasal challenge agent .</detailed_description>
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Latent Tuberculosis</mesh_term>
	<criteria>INCLUSION CRITERIA GENERAL FOR ALL SUBJECTS Males females age 18 60 year Current nonsmoker last year , maximum 10 cigs per month , smoke history &lt; 5 pack year Body mass index range1839 HEALTHY NONATOPIC VOLUNTEERS Negative skin prick test range 6 common aeroallergens : cat , dog , grass pollen , tree pollen , house dust mite , fungal spore Normal blood eosinophil count . ATOPIC SUBJECTS WITH TIMOTHY GRASS POLLEN SENSITIVITY A clinical history seasonal grass pollen allergic rhinitis : sneezing , run itch nose , nasal drip UK grass pollen summer season ( MayJuly ) . Specific allergy confirm positive intraepidermal skin prick test Timothy grass pollen extract ( Soluprick , Phleum pratense ; ALK , Horsholm , Denmark ) , positive reaction raise wheal diameter &gt; 3mm large negative saline control . ASTHMATIC SUBJECTS WITH TIMOTHY GRASS POLLEN SENSITIVITY Seasonal grass pollen allergic rhinitis : sneezing , run itch nose , nasal drip UK grass pollen summer season ( MayJuly ) . Specific allergy confirm positive intraepidermal skin prick test Timothy grass pollen extract ( Soluprick , Phleum pratense ; ALK , Horsholm , Denmark ) , positive reaction raise wheal diameter &gt; 3mm large negative saline control . Half asthmatics clinical history diagnosis asthma , require therapy occasional inhaled betaagonists , inhale corticosteroid past 28 day . Half asthmatic receive regular combine inhaled corticosteroid longacting betaagonists ( ICS/LABA ) For asthmatic resiquimod ( TLR 7/8 agonist ) arm : Methacholine PC20 &lt; 8mg/ml SUBJECTS WITH LATENT TUBERCULOSIS Healthy lung systemic symptom Positive blood Interferonγ release assay ( IGRA ) : Quantiferon TB Gold inTube ( QFTit ) , &gt; 0.35 IU/ml IFNγ versus control Tuberculin skin test ( TST ) , use RT23 tuberculin purify protein derivative ( PPD ) , Statens Serum Institut ( SSI ) Copenhagen . 2 tuberculin unit ( TU ) 0.1ml inject intradermally ( id ) : &gt; 6mm &lt; 25mm induration 4872h . Normal chest Xray ( CXR ) CT scan perform routinely clinical reason HEALTHY INTERFERONγ RELEASE ASSAY ( IGRA ) NEGATIVE VOLUNTEERS Age sex match latent TB subject Healthy lung systemic symptom Negative blood Interferonγ release assay ( IGRA ) : Quantiferon TB Gold inTube ( QFTit ) , &lt; 0.35 IU/ml IFNγ versus control Tuberculin skin test ( TST ) , use RT23 tuberculin purify protein derivative ( PPD ) , Statens Serum Institut ( SSI ) Copenhagen . 2 tuberculin unit ( TU ) 1ml inject intradermally ( id ) : &lt; 6mm induration 4872h . Chest Xray require EXCLUSION CRITERIA GENERAL Recent infection past 14 day screen : especially upper respiratory tract illness ( include cold influenza ) , sore throat , sinusitis , infective conjunctivitis . Lower respiratory tract infection past 28 day Signs symptom significant nasal anatomical defect , hypertrophy turbinate , major septum deviation , nasal polyposis injury , ulceration recurrent sinusitis Previous nasal sinus surgery Systemic illness might affect nasal immune response Medical therapy permit contraception . Treatment local systemic corticosteroid previous 1 month Antiinflammatory therapy : include nonsteroidal antiinflammatory drug ( NSAIDs ) tuberculosis stage life active infectious disease cardiovascular disease respiratory ( hay fever asthma specify ) hepatic , gastrointestinal , renal , endocrine , infective , haematological , autoimmune , rheumatological , neurological , dermatological , neoplastic condition metabolic disease extreme obesity depression psychiatric disorder Nonsmokers : 10 cigarette year permit Participation therapeutic drug trial prior 30 day . Inability unwillingness use contraception patient female childbearing age . Pregnant breast feed woman Inability provide inform consent HEALTHY NONATOPIC VOLUNTEERS Clinical history allergic rhinitis , allergic asthma eczema SUBJECTS WITH LATENT TUBERCULOSIS Clinical history active symptomatic tuberculosis ( TB ) infection Chemoprophylaxis TB HEALTHY INTERFERONγ RELEASE ASSAY ( IGRA ) NEGATIVE VOLUNTEERS Clinical history TB infection Active nasal allergy BCG vaccination</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Allergy</keyword>
	<keyword>Asthma</keyword>
	<keyword>Biomarkers</keyword>
	<keyword>Chemokines</keyword>
	<keyword>Cytokines</keyword>
	<keyword>Eosinophil</keyword>
	<keyword>Gene Expression</keyword>
	<keyword>Grass pollen</keyword>
	<keyword>Hay Fever</keyword>
	<keyword>Human Challenge Study</keyword>
	<keyword>Inflammation</keyword>
	<keyword>Innate Immune Response</keyword>
	<keyword>Lipopolysaccharide</keyword>
	<keyword>Mucosal Lining Fluid</keyword>
	<keyword>Nasal</keyword>
	<keyword>Nasorption</keyword>
	<keyword>Respiratory</keyword>
	<keyword>Respiratory Tract Infection</keyword>
	<keyword>T cell</keyword>
	<keyword>Tuberculosis</keyword>
	<keyword>Virus</keyword>
</DOC>